SLCO1B1 and Hepatitis: In patients with SLCO1B1 variants, which inhibit hepatic uptake of drugs and bile acids, the elevated bile salts are predicted to trigger antimicrobial-induced cholestasis and liver inflammation (Li et al., 2012).